Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin)

NCT02980523 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Conjunctivitis

Interventions

DRUG: PRO-157
DRUG: Vigamox
DRUG: Zymar®
DRUG: Lagricel Ofteno®

Sponsor

Laboratorios Sophia S.A de C.V.